The Treatment Advocacy Program
![]() |
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. |
ClinicalTrials.gov Identifier: NCT00164333 |
Recruitment Status
:
Completed
First Posted
: September 14, 2005
Last Update Posted
: September 27, 2012
|
- Study Details
- Tabular View
- No Results Posted
- Disclaimer
- How to Read a Study Record
Condition or disease | Intervention/treatment | Phase |
---|---|---|
HIV | Behavioral: TAP: Treatment Advocacy Program | Phase 2 |
Study Type : | Interventional (Clinical Trial) |
Enrollment : | 300 participants |
Allocation: | Randomized |
Intervention Model: | Factorial Assignment |
Masking: | None (Open Label) |
Primary Purpose: | Prevention |
Official Title: | The Treatment Advocacy Program |
Study Start Date : | September 2004 |
Actual Primary Completion Date : | May 2007 |
Actual Study Completion Date : | April 2008 |

- Self-reported, unprotected (without condoms) anal or vaginal sex with HIV-negative or unknown-status partners.
- Self-reported incidences of missed doses of treatment regimen.

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.
Ages Eligible for Study: | 18 Years and older (Adult, Senior) |
Sexes Eligible for Study: | Male |
Inclusion Criteria:
- HIV+ men who have sex with other men, age 18 or over, in HIV care at one of the collaborating clinics, any sexual contact within the previous six months.
Exclusion Criteria:
- self-reported low likelihood of remaining in treatment or in the study location for 12 months, inability to comprehend the consent quiz administered during the Consent and Enrollment Visit, or unwilling to provide required locator information

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.
Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT00164333
United States, Illinois | |
Howard Brown Medical Center | |
Chicago, Illinois, United States, 60613 |
Principal Investigator: | Dogan Eroglu, PhD. | Centers for Disease Control and Prevention |
Responsible Party: | Centers for Disease Control and Prevention |
ClinicalTrials.gov Identifier: | NCT00164333 History of Changes |
Other Study ID Numbers: |
CDC-NCHSTP-3797 R 18/CCR520972-01 |
First Posted: | September 14, 2005 Key Record Dates |
Last Update Posted: | September 27, 2012 |
Last Verified: | September 2012 |